Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus for Congenital Vascular Malformations
NCT03987152Phase 3Unknown
- Sponsor
- Radboud University Medical Center
- Start
- Sep 2017
- Primary completion
- Sep 2021
- Countries
- 1
01
Overview
A Phase 3 trial of sirolimus in vascular malformation, sponsored by Radboud University Medical Center. Status: unknown.
02
Drugs
sirolimus
03
Conditions
vascular malformation
Beyond the preview
Go deeper on NCT03987152.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03987152.